Therapeutic response to a novel enzyme-targeting radiosensitization treatment (KORTUC II) for residual lesions in patients with stage IV primary breast cancer, following induction chemotherapy with epirubicin and cyclophosphamide or taxane

Aoyama, N; Ogawa, Y; Yasuoka, M; Iwasa, H; Miyatake, K; Yoshimatsu, R; Yamanishi, T; Hamada, N; Tamura, T; Kobayashi, K; Murata, Y; Yamagami, T; Miyamura, M

Aoyama, N (reprint author), Kochi Univ, Kochi Med Sch, Dept Diagnost Radiol & Radiat Oncol, 203 Kohasu,Oko Cho, Nankoku, Kochi 7838505, Japan.

ONCOLOGY LETTERS, 2017; 13 (1): 69

Abstract

Linac-based radiotherapy has a negligible effect on the majority of advanced neoplasms. Therefore, a novel radiosensitization treatment Kochi Oxydol R......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索